Press Releases
November 4, 2026
Lupin Q2 FY2027 Results
November 4, 2026
Akhil Gupta Joins Lupin Board as Independent Director
November 3, 2026
Lupin Launches Raltegravir Tablets, USP, 600 mg in the United States
November 2, 2026
Lupin Receives U.S. FDA Approval for Amifampridine Tablets
October 23, 2026
Lupin Appoints Brian Savage as President, Chief Legal Officer
October 8, 2026
Lupin Receives U.S. FDA Approval for Phytonadione Injectable Emulsion, USP
September 28, 2026
Lupin Receives Tentative Approval from U.S. FDA for Novel Apixaban Oral Suspension
September 4, 2026
Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
August 20, 2026
Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialize YUVEZZI™ in the European Union, the United Kingdom, Switzerland, Norway, and Iceland
Media
Rajalakshmi Azariah
Vice President & Global Head - Corporate Communications
rajalakshmiazariah@lupin.comElise Titan
Director, U.S. Communications
elisetitan@lupin.comSmart Guide
Close
Search Product

Global Privacy Control Detected
We have detected your Global Privacy Control (GPC) signal. In accordance with applicable privacy laws, we have automatically honored your preference and disabled all non-essential cookies and tracking.
Only necessary cookies required for the website to function are enabled.
Opt-Out Request Honored
We have respected your privacy preference. Your opt-out request through cookie settings or Global Privacy Control signal has been honored.
